ArticleCurrent medical science2021

Efficacy and Safety of Ombitasvir plus Paritaprevir, Ritonavir and Ribavirin in Non-cirrhotic Treatment-naïve and Treatment-experienced Egyptians with Chronic HCV Genotype-4 Infection.

Manar Ahmed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.